There were statistically significant differences in CTSK immunoexpression concerning the following different variables; tumor type, tumor histologic grade, tumor size, the status of nodal involvement, metastasis, TNM clinical stage, and the incidence of recurrence (p < 0.05). Here, CTSK is linked to neoplasm.